Oxis Turbohaler (Formoterol Fumarate Dihydrate)

Formoterol fumarate dihydrate is a bronchodilator that acts on the airway smooth‑muscle pathway to improve airflow in chronic respiratory diseases.

• Asthma: improves symptom control and reduces the need for rescue inhaler use.
• Chronic obstructive pulmonary disease (COPD): enhances lung function and decreases exacerbation frequency.
• Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

• Formoterol binds selectively to β2‑adrenergic receptors on airway smooth‑muscle cells, activating adenylate cyclase and increasing intracellular cyclic AMP. The rise in cAMP leads to relaxation of smooth‑muscle fibers, producing sustained bronchodilation that lasts up to 12 hours after inhalation.

Formoterol may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Tremor: mild shaking of the hands or limbs.
• Headache: transient headache episodes.
• Throat irritation: discomfort or dryness in the throat.
• Cough: occasional dry cough after inhalation.
• Palpitations: awareness of heartbeat acceleration.
• Nausea: mild stomach upset.

Serious or Rare Side Effects

• Paradoxical bronchospasm: sudden worsening of airway obstruction.
• Cardiac arrhythmia: irregular heart rhythm requiring medical attention.
• Hypokalemia: low blood potassium levels.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Hyperglycaemia: elevated blood glucose in susceptible individuals.
• Pulmonary hypertension: increased pressure in lung arteries (very rare).

When prescribing Formoterol, clinicians should consider patient‑specific factors and follow safe handling practices.

• Assess cardiovascular risk: evaluate history of arrhythmia, hypertension, or coronary disease.
• Review asthma/COPD control: ensure the patient is on an appropriate maintenance regimen.
• Avoid abrupt discontinuation: taper if switching from high‑dose inhaled steroids.
• Monitor for paradoxical bronchospasm: educate patients to seek help if symptoms worsen after use.
• Caution in pregnancy and lactation: weigh benefits against potential risks.
• Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Formoterol can interact with several drug classes, altering its safety profile or efficacy.

Major Interactions (Avoid)

• Non‑selective β‑blockers: may diminish bronchodilator effect and precipitate bronchospasm.
• Monoamine oxidase inhibitors (MAOIs): increase risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely)

• Diuretics: may potentiate hypokalemia.
• Theophylline: additive bronchodilator effect, monitor serum levels.
• Anticholinergic inhalers: combined use may increase anticholinergic load.
• β‑agonist‑containing combination inhalers: avoid excessive β2 stimulation.
• Certain antidepressants (e.g., SSRIs): may modestly raise heart rate.